GSK
4 years ago ⋅ English ⋅ 6 min read
Newsroom
Medicago and GSK announce positive Phase 3 efficacy and safety results for adjuvanted plant-based COVID-19 vaccine candidate

For media and investors onlyIssued: London UK and Quebec City, Canada- Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 var... Read More
GSK
4 years ago ⋅ English ⋅ 12 min read
Newsroom
Preclinical studies demonstrate sotrovimab retains activity against the full combination of mutations in the spike protein of the Omicron SARS-CoV-2 variant

For media and investors onlyIssued: London UK and San Francisco US- New preclinical findings generated through in vitro testing of sotrovimab against the complete pseudo-virus, updated... Read More
GSK
4 years ago ⋅ English ⋅ 2 min read
Newsroom
GSK welcomes Gavi decision to fund the roll out of malaria vaccines for children

Issued: 2 December, London UKGlaxoSmithKline (GSK) plc today welcomed the decision of the Gavi Board to provide funding for the procurement and introduction of malaria vaccines into rou... Read More
GSK
4 years ago ⋅ English ⋅ 8 min read
Newsroom
MHRA grants conditional marketing authorisation1 for COVID-19 treatment Xevudy (sotrovimab)

MHRA grants conditional marketing authorisation1 for COVID-19 treatment Xevudy (sotrovimab)Issued: 2 December, London UK- Conditional marketing authorisation has been granted for Great... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

For media and investors onlyIssued: 2 December, London UK- Major new collaboration aims to deepen understanding of complex diseases such as Alzheimer’s and Parkinson’s, and... Read More
GSK
4 years ago ⋅ English ⋅ 11 min read
Newsroom
Preclinical data demonstrate sotrovimab retains activity against key Omicron mutations, new SARS-CoV-2 variant

For media and investors only- Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, includ... Read More